Definium Therapeutics, Inc. (DFTX)
$34.18-2.59%Close
SELLBEAR · day 9
Key stats
Short interest · FINRA settlement 2026-09-15
- Market cap
- $3.7B
- Beta
- 2.19
- P/E (TTM)
- -10.35
- Short % float
- 10.99%
- Days to cover
- 5.2
- SI change
- +19.8%
- 1W
- -9.10%
- 1M
- -10.03%
- vs SPY 1W
- -10.65%
- vs SPY 1M
- -11.79%
Industry peers
FMP comparable companies · ranked by market cap
- KODBUYKodiak Sciences Inc.$5.9BBULLQ 41$93.81+3.49%
- TNGXSELLTango Therapeutics, Inc.$3.8BCRISISQ 23$23.08+3.39%
- NRIXSELLNurix Therapeutics, Inc.$2.4BBEARQ 11$22.88-2.29%
- URGNSELLUroGen Pharma Ltd.$2.1BCRISISQ 22$42.78-9.14%
- FTREBUYFortrea Holdings Inc.$2.0BBULLQ -2$21.11-0.92%
- XNCRSELLXencor, Inc.$1.9BRECOVERYQ 15$25.63+0.99%
- ANABSELLAnaptysBio, Inc.$1.5BCRISISQ 25$49.20+1.23%
- SVRASELLSavara Inc.$980MCRISISQ 11$4.78-1.02%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 20
- VALUE
- 8
- GROWTH
- 47
- GARP
- 6
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC-51.1%
REV YoY-
ROE-85.2%
EPS YoY-
ROA-31.8%
GROSS0
OP0
NET0
[VALUATION]
P/E TTM-10.35
P/E FWD-
SECTOR PE20.12
INDUSTRY PE13.79
P/B4.29
P/FCF-
EV/EBITDA-12.10
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E3.97
ALTMAN Z-
CURR RATIO6.95
ND/EBITDA-
BETA2.19
